{"Symbol": "ABBV", "AssetType": "Common Stock", "Name": "AbbVie Inc", "Description": "AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.", "CIK": "1551152", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "DRUG MANUFACTURERS - GENERAL", "Address": "1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, UNITED STATES, 60064-6400", "OfficialSite": "https://www.abbvie.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-12-31", "MarketCapitalization": "409149538000", "EBITDA": "29416665000", "PERatio": "98.09", "PEGRatio": "0.388", "BookValue": "-1.495", "DividendPerShare": "6.65", "DividendYield": "0.0292", "EPS": "2.36", "RevenuePerShareTTM": "34.49", "ProfitMargin": "0.0691", "OperatingMarginTTM": "0.35", "ReturnOnAssetsTTM": "0.0959", "ReturnOnEquityTTM": "0.111", "RevenueTTM": "61160002000", "GrossProfitTTM": "43818000000", "DilutedEPSTTM": "2.36", "QuarterlyEarningsGrowthYOY": "-0.887", "QuarterlyRevenueGrowthYOY": "0.1", "AnalystTargetPrice": "245.33", "AnalystRatingStrongBuy": "6", "AnalystRatingBuy": "13", "AnalystRatingHold": "9", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "1", "TrailingPE": "98.09", "ForwardPE": "16.03", "PriceToSalesRatioTTM": "6.69", "PriceToBookRatio": "50.46", "EVToRevenue": "7.72", "EVToEBITDA": "31.32", "Beta": "0.334", "52WeekHigh": "241.12", "52WeekLow": "159.05", "50DayMovingAverage": "223.8", "200DayMovingAverage": "210.63", "SharesOutstanding": "1767385000", "SharesFloat": "1763921000", "PercentInsiders": "0.108", "PercentInstitutions": "76.370", "DividendDate": "2026-02-17", "ExDividendDate": "2026-01-16"}